Mesenchymal stem cells (MSC) are characterized by their multilineage differentiation capacity and immunosuppressive properties. They are resident in virtually all tissues and we have recently characterized MSC from the human heart. Clinical heart transplantation offers a model to study the fate of transplanted human MSC. In this study, we isolated and expanded MSC from heart tissue taken before, and 1 week up to 6 years after heart transplantation. MSC from posttransplantation tissue were all of donor origin, demonstrating the longevity of endogenous MSC and suggesting an absence of immigration of recipient MSC into the heart. MSC isolated from transplanted tissue showed an immunophenotype that was characteristic for MSC and maintained card...
Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However,...
Purpose: Several literature reports indicated the existence of pluripotent cells residing into the h...
Background—Cardiac cell therapy for older patients who experience a myocardial infarction may requir...
Mesenchymal stem cells (MSC) are characterized by their multilineage differentiation capacity and im...
Mesenchymal stem cells (MSC) are characterized by their multilineage differentiation capacity and im...
Mesenchymal stem cells (MSC) are pluripotent cells which reside in several adult organs, including h...
It has been proposed the use of resident stem cells (SCs) for the repair of cardiac injuries. Howeve...
Mesenchymal stem cells (MSCs) are virtually present in all postnatal organs as well as in perinatal ...
Purpose: Mesenchymal stem cells (MSC) are pluripotent cells which are known to reside in a number of...
Background: Human mesenchymal stem cells (hMSC), human embryonic stem cells (HESC) and human fetal c...
Cardiac stem cells were identified in mammalian hearts and they were found to regenerate cardiomyocy...
Abstract—Mesenchymal stem cells (MSCs) represent a stem cell population present in adult tissues tha...
Rationale: Chronic rejection, accelerated coronary atherosclerosis, myocardial infarction, and ische...
AbstractRegeneration of the myocardium by transplantation of cardiomyocytes is an emerging therapeut...
Mesenchymal stem cells (MSC) are adult stem cells with capacity for self-renewal and multi-lineage d...
Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However,...
Purpose: Several literature reports indicated the existence of pluripotent cells residing into the h...
Background—Cardiac cell therapy for older patients who experience a myocardial infarction may requir...
Mesenchymal stem cells (MSC) are characterized by their multilineage differentiation capacity and im...
Mesenchymal stem cells (MSC) are characterized by their multilineage differentiation capacity and im...
Mesenchymal stem cells (MSC) are pluripotent cells which reside in several adult organs, including h...
It has been proposed the use of resident stem cells (SCs) for the repair of cardiac injuries. Howeve...
Mesenchymal stem cells (MSCs) are virtually present in all postnatal organs as well as in perinatal ...
Purpose: Mesenchymal stem cells (MSC) are pluripotent cells which are known to reside in a number of...
Background: Human mesenchymal stem cells (hMSC), human embryonic stem cells (HESC) and human fetal c...
Cardiac stem cells were identified in mammalian hearts and they were found to regenerate cardiomyocy...
Abstract—Mesenchymal stem cells (MSCs) represent a stem cell population present in adult tissues tha...
Rationale: Chronic rejection, accelerated coronary atherosclerosis, myocardial infarction, and ische...
AbstractRegeneration of the myocardium by transplantation of cardiomyocytes is an emerging therapeut...
Mesenchymal stem cells (MSC) are adult stem cells with capacity for self-renewal and multi-lineage d...
Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However,...
Purpose: Several literature reports indicated the existence of pluripotent cells residing into the h...
Background—Cardiac cell therapy for older patients who experience a myocardial infarction may requir...